Clinical Enroll

Built for the research sites the standard model was failing.

Clinical research sites are understaffed, underpaid relative to their coordination burden, and routinely burned by vendors who bill for activity rather than results.

A different premise from the start.

Clinical Enroll was built on a different premise from the standard recruitment model. Coordinators pre-screen referrals that fail basic eligibility. Studies slip timelines while invoices arrive on schedule. The site absorbs the gap in enrollment and the downstream pressure on its sponsor relationship.

We looked at that model and asked a simple question: what if the recruitment partner's financial outcome was tied to the same outcome the site cared about?

That question is the foundation of how Clinical Enroll operates. Feasibility first. Pre-screened referrals only. An outcome guaranteed or a fee returned.

Clinical trial data printout

Two problems the standard model created. Both avoidable.

The coordinator burden problem

When a recruitment vendor sends unqualified referrals — patients who have not been evaluated against inclusion/exclusion criteria — your site coordinators carry the screening load. A coordinator reviewing forty referrals to find two eligible patients isn't a workflow problem. It's a vendor accountability problem.

Coordinator burnout at high-volume sites tracks directly to low-quality referral pipelines. Pre-screened referrals are not a convenience. They are a structural requirement for a model that respects coordinator capacity.

The effort-based billing problem

Traditional recruitment agencies bill for activity: impressions delivered, clicks generated, media spend placed. These are activity metrics. Activity metrics measure what a vendor did, not what your study needed.

When a campaign underperforms, the vendor invoices on time and moves on. Your site absorbs the enrollment gap and the downstream pressure on your sponsor relationship. “Best effort” is not a performance standard when your study timeline determines protocol viability.

Three structural differences. One accountable outcome.

Feasibility first

We evaluate every study before we commit to it. Patient pool, eligibility complexity, site capacity, enrollment target math. If the study qualifies for a guarantee, we say so in writing. If it doesn't, we tell you why, before you spend anything. We decline engagements we're not confident in. That's by design.

Pre-screened referrals only

What your coordinator receives is not a lead list. It is a referral packet: a patient who has completed a protocol-specific questionnaire aligned to the study's inclusion/exclusion criteria. Patients who don't meet the criteria threshold are not referred. Your coordinator's job is informed consent screening, not lead filtering.

Guaranteed outcome or fee returned

For qualifying studies, we commit to delivering the contracted enrollment target. If we miss it, we run a second campaign at no charge. If the re-run also falls short, you receive a full refund. No partial credits. No retained fees. The guarantee is a contractual term written into the engagement agreement before any campaign is built.

Find out if your study qualifies.

If your study qualifies, working with us carries no financial risk. That is by design. Submit an NCT ID or a link to your inclusion criteria to get started.

All campaigns developed for IRB review and deployed in accordance with FDA guidance on clinical trial advertising.